SNTI
Senti Biosciences Inc
0.323$
-6.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6,031.0% | -2,113.2% | -3,508.1% | – | – | -230.6% | – | – | – | -31,250.0% | -46,756.3% | -83,817.6% | -69,183.6% | |
| 711.8% | 442.6% | 438.7% | – | – | 24.9% | – | – | – | 6,613.6% | 4,300.0% | 3,923.5% | 4,745.5% | |
| 160.4% | 619.8% | 377.8% | – | – | 10.3% | – | – | – | 6,477.3% | 8,218.8% | 6,164.7% | 9,707.3% | |
| -228.6% | 1,796.1% | 32.4% | – | – | -24.9% | – | – | – | 1,009.1% | 9,037.5% | -19,070.6% | 10,463.6% | |
| 728.6% | 1.2% | 4.5% | – | – | 0.2% | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| 8,291.0% | 30.3% | -4.5% | – | – | -0.2% | – | – | – | 54.5% | 712.5% | – | – | |
| – | -3,620,486.2% | -3,620,486.2% | – | – | -0.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -41.5% | – | – | – | – | – | – | – | |
| -9.0% | 167.0% | 167.0% | – | – | 875.9% | – | – | – | 50,181.8% | -737.5% | 56,911.8% | 37,674.5% | |
| 2,251.0% | -1,915.9% | -3,512.6% | – | – | 645.5% | – | – | – | 18,931.8% | -46,781.3% | -26,905.9% | -31,301.8% | |
| -6,759.6% | -2,114.4% | -3,512.6% | – | – | -230.8% | – | – | – | -31,250.0% | -46,756.3% | -83,817.6% | -69,183.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.